CBIO Crescent Biopharma Inc.

Price (delayed)

$14.19

Market cap

$527.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.63

Enterprise value

$356.81M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 19
Highlights
The company's EPS has surged by 88% YoY and by 35% QoQ
The debt has declined by 13% year-on-year and by 7% since the previous quarter
Crescent Biopharma's equity has increased by 17% YoY but it has decreased by 11% from the previous quarter
Crescent Biopharma's net income has shrunk by 155% YoY
CBIO's quick ratio is down by 31% QoQ

Key stats

What are the main financial stats of CBIO

CBIO stock price

How has the Crescent Biopharma stock price performed over time
Intraday
-13.69%
1 week
-17.4%
1 month
-17.26%
1 year
9.58%
YTD
19.65%
QTD
-21.17%

Financial performance

How have Crescent Biopharma's revenue and profit performed over time
Revenue
$10.84M
Gross profit
$10.84M
Operating income
-$171.28M
Net income
-$165.12M
Gross margin
100%
Net margin
-1,522.7%
Crescent Biopharma's operating income has plunged by 169% YoY and by 4.3% from the previous quarter
Crescent Biopharma's net income has shrunk by 155% YoY
The operating margin has declined by 4.3% since the previous quarter

Price vs fundamentals

How does CBIO's price correlate with its fundamentals

Growth

What is Crescent Biopharma's growth rate over time

Valuation

What is Crescent Biopharma stock price valuation
P/E
N/A
P/B
2.4
P/S
39.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.9
The company's EPS has surged by 88% YoY and by 35% QoQ
CBIO's price to book (P/B) is 39% higher than its 5-year quarterly average of 2.0 and 39% higher than its last 4 quarters average of 2.0
Crescent Biopharma's equity has increased by 17% YoY but it has decreased by 11% from the previous quarter

Efficiency

How efficient is Crescent Biopharma business performance
The ROE has grown by 47% YoY
Crescent Biopharma's return on assets has increased by 28% YoY
The company's return on sales fell by 2.6% QoQ

Dividends

What is CBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CBIO.

Financial health

How did Crescent Biopharma financials performed over time
CBIO's quick ratio is down by 31% QoQ
Crescent Biopharma's current ratio has decreased by 30% QoQ but it has increased by 4.9% YoY
The debt is 99% smaller than the equity
Crescent Biopharma's equity has increased by 17% YoY but it has decreased by 11% from the previous quarter
The debt has declined by 13% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.